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Abstract
Background: To date, appropriate management for Bethesda IV thyroid nodules is controversial, and no specific
features of follicular neoplasm and nodular hyperplasia on ultrasonography, computed tomography (CT), or other
imaging modalities have been reported. This study aimed to compare CT features of follicular neoplasm and
nodular hyperplasia and to determine the specific CT features that could be used to distinguish follicular neoplasm
from nodular hyperplasia.
Methods: In 122 patients who underwent preoperative CT of the neck and thyroid surgery, 59 follicular neoplasms
and 65 nodular hyperplasias were included. In each case, non-enhanced and contrast-enhanced CT images were
obtained, and a single radiologist retrospectively analyzed CT images, including degree and pattern of attenuation,
nodular configuration, margin, shape, pattern of calcification, degree and pattern of nodular enhancement, and CT
halo sign. A univariate and multivariate logistic regression analyses were used to evaluate the predictive power of
each variable and CT features with a high predictive power, respectively.
Results: According to the univariate analysis, iso-attenuation, intraglandular configuration, smooth margin, ovoid
shape, decreased enhancement, and absence of CT halo sign were more frequently observed in nodular
hyperplasia (p < 0.05), whereas low attenuation, expansile configuration, lobulated margin, taller-than-wide shape,
increased enhancement, and presence of computed tomography halo sign were more frequently observed in
follicular neoplasm (p < 0.05). Multivariate analysis revealed significant differences in configuration (OR: 2.73, 1.13–6.
57), degree of enhancement (OR: 2.14, 1.21–3.78), and presence of CT halo sign (OR: 7.97, 2.74–23.37) between
follicular neoplasm and nodular hyperplasia (p < 0.05).
Conclusions: Neck CT may be helpful for distinguishing follicular neoplasm from nodular hyperplasia.
Trial registration: Rretrospectively registered.
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Background
Follicular neoplasm (FN) of the thyroid gland includes
follicular adenoma and follicular carcinoma [1]. When
FN is suspected on cytology after ultrasonography (US)-
guided fine-needle aspiration (US-FNA) of a thyroid
nodule (i.e., Bethesda IV class, which is characterized by
a high cellularity, scant or absent colloid, and follicular
cells with predominantly microfollicular or trabecular ar-
rangements), surgery is recommended because no diag-
nostic method has been established to distinguish
follicular carcinoma from follicular adenoma, except for
surgery [2]. Herein, US-FNA has an important limitation
in the preoperative detection of FN and show relatively
high false-positive rate, ranging from 20 to 40 % in the
literature [3–5]. The main thyroid nodule that mimics
FN on cytology, is nodular hyperplasia (NH), which is
characterized by a dense cellular follicular proliferation
with no fibrous capsule on histopathology [6].
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Furthermore, a core needle biopsy is not recommended
for the management of a Bethesda IV nodule because it
cannot provide useful information [7]. Therefore, un-
necessary surgery for in cases of Bethesda IV nodules is
not uncommon [5, 8].
Several studies have attempted to compare the imaging
features between NH and FN [9–11]. Several investigators
have proposed that NH can be differentiated from follicu-
lar adenoma by using US, including the ratio of solid and
cystic portion, spongiform appearance, and echogenicity
of thyroid nodules [9]. Other investigators have reported
that 18F-fluorodeoxyglucose (18F-FDG) positron emission
tomography/computed tomography (CT) can prevent a
significant number of unnecessary thyroid surgeries when
the nodules are larger than 2 cm or in cases of high 18F-
FDG uptake without oncocytic changes [11]. However, no
specific features of follicular neoplasm and nodular hyper-
plasia on US, CT, or other imaging modalities have been
established. To the best of our knowledge, no comparative
study of CT features between NH and FN has been pub-
lished. This study aimed to compare the CT features of
FN and NH and to determine the specific CT features that
can distinguish FN from NH.
Methods
Study population
This retrospective study was approved by the Institutional
Review Board, and informed consent of the patients was
waived. From March 2010 to June 2014, 83 patients (mal-
e:female = 11:72, mean age: 49.7 years, age range: 28–78
years) underwent thyroid surgery in our institution for the
treatment of FN. Of the 83 patients with FNs, 26 were ex-
cluded because of the absence of a preoperative neck CT
scan (n = 11), mismatch between CT and histopathological
findings (n = 2), small nodule size < 1 cm at the largest
diameter (n = 8), and poor image quality of CT (n = 5). Fi-
nally, 59 FNs in 57 patients (male:female = 12:45, mean
age: 50.4 years, range: 28–78) were included in this study.
From August 2013 to June 2014, 289 patients (male:fe-
male = 32:257, mean age: 52.2 years, age range: 22–79
years) underwent thyroid surgery for the treatment of
thyroid malignancy or other thyroid lesions, and 159
had one or more NHs on histopathological analysis. Of
the 159 patients, 94 were excluded because of the ab-
sence of a preoperative neck CT scan (n = 52), mismatch
between CT and histopathological findings (n = 5), small
nodule size < 1 cm at the largest diameter (n = 25), and
poor image quality of CT (n = 12). Finally, 65 NHs in 65
patients (male:female = 5:60, mean age: 55.7 years, age
range: 22–61 years) were included.
Neck CT
Neck CT examinations were performed with multi-
detector CT scanners (Discovery CT750 HD, GE
Healthcare, Milwaukee, USA; Aquilion One, Toshiba
Medical System Corporation, Tokyo, Japan). The scout
view was scanned through the lateral projection. Both
non-enhanced and contrast-enhanced images of the
neck, skull base, and superior mediastinum were ob-
tained. The acquisition parameters for Aquilion One
were 120 kV; 180 mA; rotation time, 0.5 s; pitch, 0.625;
field of view, 35 cm; matrix size, 512 × 512 pixel; de-
tector collimation, 64 mm× 0.5 mm; slice thickness,
1 mm; slice increment, 1 mm. The acquisition parameters
for Discovery CT750 HD were filed of view, 30 cm; slice
thickness, 1.25; and slice increment, 1.25 mm. The other
parameters were approximately the same as those of
Aquilion One. A contrast-enhanced image was obtained
after the intravenous injection of contrast media (300 mg
of non-ionized iodine per milliliter, Scanlux; Sanochemia
Pharmazeutika AG, Leitha, Austria) at 3 mL/s, delayed
until 40 s after the initiation of contrast media.
Image analysis
A single radiologist with 3 years of experience in head and
neck imaging performed an image analysis using a picture
archiving and communication system under blinded con-
ditions for the histopathological results. The following CT
features of thyroid nodules were retrospectively investi-
gated: the degree and pattern of attenuation, configur-
ation, margin, shape, pattern of calcification, degree and
pattern of enhancement, and presence of a CT halo sign
(defined as a low-attenuated rim ≥ 1 mm in thickness and
surrounding ≥ 75 % of the peripheral margin of the thyroid
nodule on either non-enhanced or contrast-enhanced CT
image). To determine the degrees of attenuation and en-
hancement of thyroid nodules on non-enhanced and
contrast-enhanced images, respectively, the adjacent thy-
roid parenchyma was used as a reference. The patterns of
attenuation and enhancement of thyroid nodules on CT
were classified as homogeneous or inhomogeneous. The
configuration of the thyroid nodules was divided into
intraglandular (the presence of thyroid parenchyma be-
tween the nodule and adjacent thyroid capsule), expansile
(with a blunt angle between the lesion and adjacent thy-
roid capsule), or exophytic (with an acute angle between
the lesion and adjacent thyroid capsule). The margin of
the thyroid nodules was classified as smooth, irregular,
lobulated, or poorly defined. The shape was classified
based on the ratio of anteroposterior to transverse diame-
ters in axial images as follows: (1) anteroposterior and
transverse diameters of the nodule should be parallel with
the anteroposterior and transverse axes of the thyroid
gland, respectively. (2) the shape of the thyroid nodules
was divided into ovoid (anteroposterior diameter/trans-
verse diameter ratio ≤ 0.8), round (0.8 < anteroposterior
diameter/transverse diameter ratio ≤ 1), or taller-than-
wide (anteroposterior diameter/transverse diameter ratio >
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1). Based on the degree of calcification, the thyroid nodule
was classified as non-calcified, rim, nodular, punctate (tiny
dot-like calcification), complete, or mixed (nodular plus
punctate). The degree of nodular enhancement was classi-
fied as no/scant, decreased, iso-, and increased, based on a
comparison with the adjacent thyroid parenchyma. CT
halo sign was classified as absent or present.
To avoid investigation bias, nodule selection and
image analysis were independently performed in two
stages: (1) First, the selection, localization, and measure-
ment of a thyroid nodule in all patients were performed
on the basis of the CT and histopathological findings by
a single radiologist. (2) After 4 weeks, image analysis of
the thyroid nodules was performed by the same radiolo-
gist blinded to the histopathological findings.
Statistical analysis
The data were tested for normal distribution by using a
Kolmogorov–Smirnov test. Age at the time of diagnosis
and nodular size were expressed as the mean ± standard
deviation. Mean differences in age and nodule size be-
tween FN and NH were compared using the independ-
ent t-test. Group comparisons of categorical variables
were performed using the χ2 test. A univariate logistic
regression analysis was first used to evaluate the predict-
ive power of each variable. CT features with a high pre-
dictive power (p < 0.20, Wald test) were selected and
analyzed by multivariate logistic regression analysis to
determine an optimal logistic regression model for dis-
tinguishing NH from FN. A receiver operating charac-
teristic (ROC) curve analysis was performed to evaluate
the diagnostic performance of CT features, and the area
under the ROC curve (AUC) was compared between the
two groups. All statistical analyses were performed with
a statistical software (SPSS, version 17.0, SPSS, Chicago,
IL, USA), and a p value less than 0.05 was considered
statistically significant.
Results
In the 122 patients (male:female = 14:108, mean age:
52.9 years, age range: 22–78 years) included in this
study, 59 FN and 65 NH were investigated. The type of
thyroid surgery included total thyroidectomy (n = 93),
subtotal thyroidectomy (n = 1), and hemi-thyroidectomy
(n = 28). The mean age of the patients with FN was sig-
nificantly lower than those with NH (50.4 ± 14.9 vs 55.7
± 11.8, p = 0.031). The mean nodule size was not signifi-
cantly different between FN and NH (2.66 ± 1.64 cm vs
2.13 ± 1.62 cm, respectively, p = 0.069). Of the 59 FNs in
57 patients, 9 follicular carcinomas and 50 follicular ad-
enomas were found. The reasons for thyroid surgery in-
cluded coexisting thyroid malignancy (n = 9), suspicious
follicular neoplasm (n = 25), suspicious malignancy (n =
8), or atypia of undetermined significance or follicular
lesion of undetermined significance on cytology (n = 14),
and patient request despite benign cytology (n = 1).
The CT features of FN and NH are listed in Table 1.
CT features common to both FN and NH included low
and inhomogeneous attenuation, smooth margin, round
shape, no calcification, and inhomogeneous enhance-
ment. The prevalence of expansile configuration, in-
creased enhancement, and presence of the CT halo sign
was higher in FN (Fig. 1), whereas the prevalence of
intraglandular configuration, decreased enhancement,
and absence of the CT halo sign was higher in NH
(Fig. 2). In particular, the CT halo sign was more fre-
quently observed in FN than NH. In univariate analysis,
degree of attenuation, configuration, margin, shape, de-
gree of enhancement, and the CT halo sign were signifi-
cantly different between FN and NH (p < 0.05, Table 1).
Iso-attenuation, intraglandular configuration, smooth
margin, ovoid shape, decreased enhancement, and ab-
sence of the CT halo sign were more frequent in NH,
whereas low attenuation, expansile configuration, lobu-
lated margin, taller-than-wide shape, increased enhance-
ment, and presence of the CT halo sign were more
frequent in FN. However, pattern of attenuation, calcifi-
cation, and pattern of enhancement were not signifi-
cantly different between FN and NH (p > 0.05). In
multivariate analysis, configuration (OR: 2.73, 1.13–6.57,
p = 0.026), degree of enhancement (OR: 2.14, 1.21–3.78,
p = 0.009), and the CT halo sign (OR: 7.97, 2.74–23.37,
p < 0.001) were significantly different between FN and
NH (Table 2).
The diagnostic indices of individual CT features for
distinguishing FN from NH are presented in Table 3.
The AUC values for expansile configuration, taller-than-
wide shape, increased enhancement, and presence of the CT
halo sign were significantly higher in FN (95 % CI, p < 0.05).
Discussion
US-FNA has been established as the first method of
choice for evaluating sonographically suspicious thyroid
nodules. For reporting thyroid cytopathology, the Be-
thesda system, including 6 classes, has been used world-
wide [2]. Although the Bethesda system has discrete
advantage in terms of communication between cyto-
pathologists, physicians, and other clinicians, several
limitations should be considered. One of the limitations
is that Bethesda IV nodules include a significant propor-
tion of non-neoplastic lesions (up to 35 %) [2, 5, 12].
NH is often classified as Bethesda class IV, because it
has a similar histopathological appearance to FN, and
the absence of a fibrous capsule cannot be evaluated on
cytology [6, 13]. In this case, core needle biopsy is not
helpful for identifying NH among Bethesda class IV nod-
ules, resulting in unnecessary thyroid surgery [7].
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Several investigators have attempted to distinguish
malignant thyroid nodules from benign nodules on CT
[14–16]. They suggested that calcification, taller-than-
wide shape, and high degree of nodular enhancement
were meaningful CT features for thyroid malignancy [15,
16]. Although previous CT studies have focused on
distinguishing malignancy from benign nodules, the
focus of our study was to determine specific CT features
for distinguishing FN from a non-neoplastic nodule. The
results of this study showed that the combination of ex-
pansile configuration, increased enhancement, and the
presence of a CT halo sign suggests the possibility of FN
Table 1 Univariate logistic regression analysis of computed tomography features of nodular hyperplasia and follicular neoplasm
CT features Nodular hyperplasia (n = 65) Follicular neoplasm (n = 59) p value
Degree of attenuation
no visualization 5 (7.7 %) 0 (0 %) <0.001
low 44 (67.7 %) 57 (96.6 %)
iso- 15 (23.1 %) 1 (1.7 %)
high 1 (1.5 %) 1 (1.7 %)
Pattern of attenuation
homogeneous 25 (38.4 %) 19 (32.2 %) 0.466
inhomogeneous 40 (61.6 %) 40 (67.8 %)
Configuration
intraglandular 41 (63.1 %) 21 (35.6 %) 0.003
expansile 18 (27.7 %) 34 (57.6 %)
exophytic 6 (9.2 %) 4 (6.8 %)
Margin
smooth 42 (64.7 %) 34 (57.6 %) 0.023
irregular 1 (1.5 %) 0 (0 %)
lobulated 16 (24.6 %) 25 (42.4 %)
poorly defined 6 (9.2 %) 0 (0 %)
Shape
ovoid 26 (40 %) 10 (16.9 %) 0.008
round 29 (44.6 %) 30 (50.9 %)
taller-than-wide 10 (15.4 %) 19 (32.2 %)
Calcifications
none 59 (90.8 %) 48 (81.3 %) 0.186
rim (eggshell) 1 (1.5 %) 2 (3.4 %)
nodular 2 (3.1 %) 6 (10.2 %)
punctate 2 (3.1 %) 0 (0 %)
mixed* 1 (1.5 %) 3 (5.1 %)
Degree of enhancement
no/scant 4 (6.2 %) 0 (0 %) < 0.001
decreased 29 (44.5 %) 18 (30.5 %)
iso- 25 (38.5 %) 15 (25.4 %)
increased 7 (10.8 %) 26 (44.1 %)
Pattern of enhancement
homogeneous 13 (20 %) 4 (6.8 %) 0.06
inhomogeneous 52 (80 %) 55 (93.2 %)
CT halo sign
absent 54 (83.1 %) 17 (28.8 %) < 0.001
present 11 (16.9 %) 42 (71.2 %)
Note. — *, ‘Mixed’ means punctate plus nodular calcifications. Data are number of items, with percentage in parentheses. CT computed tomography
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rather than NH. In terms of the configuration and shape
of thyroid nodules, FN tends to reveal expansile config-
uration and taller-than-wide shape, whereas NH tends to
represent intraglandular configuration and ovoid shape.
This difference may originate from the essentials of NH
and FN: FN is a neoplasm of the thyroid gland, whereas
NH is a non-neoplastic condition [17, 18]. Regarding CT
enhancement of thyroid nodules, increased enhance-
ment was more frequently observed in FN than in NH.
This finding is concordant with that of a previous study,
in which FN tended to have less cystic degeneration and
scant colloid in comparison with NH [19].
The well-known US halo sign (i.e., hypoechoic rim
around thyroid nodules) is generated by a pseudocapsule
of fibrous connective tissue, which appears as com-
pressed normal adjunct parenchyma or inflammatory
cell infiltration on histopathology [20, 21]. One study
reported that a complete, even halo sign was suggest-
ive of benignity with specificity of 95 % [22], whereas
another study reported that more than half of benign
nodular thyroid diseases revealed no US halo sign
[21]. In the present study, we first used the CT halo
sign of a thyroid nodule. The CT halo sign was ob-
served in both FN and NH, but their frequency was
higher in FN (71.2 %, 42/59). The prevalence rate of
the halo sign in FN was higher than that of the US
halo sign (50 %, 21/42) in a previous study [9]. In
our study, the prevalence rate of the CT halo sign
was higher in FN (71.2 %, 42/59) than in NH
(16.9 %, 11/54). This might be because FN has a high
incidence of discrete fibrous capsule, whereas NH has
a low incidence of discrete fibrous capsule. For clar-
ity, further studies, including a larger number of
cases, should be required. Separately, further CT
Fig. 1 A 51-year-old woman with follicular adenoma in the left thyroid
lobe (largest diameter, 1.9 cm). In non-enhanced (a) and contrast-
enhanced (b) axial CT images, follicular adenoma (arrows) in the left
thyroid lobe shows homogeneous low attenuation, mildly expansile
configuration, taller-than-wide shape, inhomogeneous and increased
enhancement, and presence of the CT halo sign (arrowheads)
Fig. 2 A 62-year-old man with nodular hyperplasia in the left thyroid
lobe (largest diameter, 3.5 cm). In non-enhanced (a) and contrast-
enhanced (b) axial CT images, nodular hyperplasia (arrows) in the left
thyroid lobe shows inhomogeneous iso-attenuation, ovoid shape,
homogeneous iso-enhancement, and absence of the CT halo sign
Table 2 Multivariate logistic regression analysis of computed
tomography features for distinguishing follicular neoplasm from
nodular hyperplasia
CT features Odds Ratio* p value
Type of attenuation 0.40 (0.11, 1.40) 0.149
Pattern of attenuation 0.58 (0.20, 1.72) 0.328
Configuration 2.73 (1.13, 6.57) 0.026
Margin 0.72 (0.43,1.22) 0.224
Shape 1.88 (0.89, 3.98) 0.098
Calcifications 1.44 (0.90. 2.23) 0.128
Degree of enhancement 2.14 (1.21, 3.78) 0.009
Pattern of enhancement 1.95 (0.422, 3.02) 0.393
CT halo sign 7.97 (2.74, 23.37) < 0.001
Note. — *, Numbers in parentheses are 95 % confidence intervals. CT
computed tomography
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studies using multiple phase or dynamic enhancement
may be necessary for evaluating specific enhancing
pattern of NH or FN.
This study has several limitations. First, the analysis of
CT features was performed by a single radiologist. For
clarity, a multicenter study should be conducted in the
future. Second, all patients underwent thyroid surgery.
Furthermore, thyroid nodules < 1 cm at the largest diam-
eter were not included. Thus, selection bias could not be
avoided. Third, the analysis of attenuation and enhance-
ment in thyroid nodules was performed only by visual
assessment. Hounsfield unit of a thyroid nodule in the
evaluation of attenuation or enhancement was not mea-
sured. Finally, the presence or absence of underlying dif-
fuse thyroid disease was not considered. Because the
adjacent thyroid parenchyma was used as a reference to
analyze the degree of attenuation and enhancement, vis-
ual assessment of nodules might be affected according
to the presence of an underlying diffuse thyroid disease.
Conclusions
The results of this study showed that FN is indicated by
expansile configuration, increased enhancement, and
presence of the CT halo sign, whereas NH is indicated
by intraglandular configuration, decreased enhancement,
and absence of the CT halo sign. Therefore, neck CT
may be helpful to differentiate FN from NH.
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